ENTERO HEALTHCARE SOLUTIONS Financial Statement Analysis
|
||
The Revenues of ENTERO HEALTHCARE SOLUTIONS have increased by 18.85% YoY .
The Earnings Per Share (EPS) of ENTERO HEALTHCARE SOLUTIONS has increased by 142.38 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
ENTERO HEALTHCARE SOLUTIONS Last 5 Annual Financial Results
[BOM: 544122|NSE : ENTERO]
Consolidated | Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
---|---|---|---|---|---|
Revenues | ₹3,922 Cr | ₹3,300 Cr | ₹2,522 Cr | ₹1,780 Cr | ₹1,780 Cr |
Expenses | ₹3,810 Cr | ₹3,236 Cr | ₹2,498 Cr | ₹1,758 Cr | ₹1,758 Cr |
Operating Profit (Excl OI) | ₹112 Cr | ₹64 Cr | ₹24 Cr | ₹22 Cr | ₹22 Cr |
Other Income | ₹14 Cr | ₹5.51 Cr | ₹4.48 Cr | ₹3.93 Cr | ₹3.93 Cr |
Interest | ₹66 Cr | ₹49 Cr | ₹29 Cr | ₹20 Cr | ₹20 Cr |
Depreciation | ₹25 Cr | ₹24 Cr | ₹20 Cr | ₹16 Cr | ₹16 Cr |
Profit Before Tax | ₹36 Cr | ₹-3.69 Cr | ₹-20 Cr | ₹-11 Cr | ₹-11 Cr |
Profit After Tax | ₹40 Cr | ₹-11 Cr | ₹-29 Cr | ₹-15 Cr | ₹-15 Cr |
Consolidated Net Profit | ₹39 Cr | ₹-12 Cr | ₹-30 Cr | ₹-16 Cr | ₹-16 Cr |
Earnings Per Share (Rs) | ₹21.79 | ₹8.99 | ₹-28.11 | ₹-77.71 | ₹-1,553.70 |
PAT Margin (%) | 2.11 | 1.01 | -0.34 | -1.17 | -0.86 |
ROE(%) | 6.40 | 5.08 | 0.00 | 0.00 | 0.00 |
ROCE(%) | 9.16 | 7.02 | 4.99 | 1.24 | 1.47 |
Total Debt/Equity(x) | 0.17 | 0.17 | 0.63 | 0.51 | 0.29 |
Key Financials |
||
Market Cap | : | ₹ 4,813.5 Cr |
Revenue (TTM) | : | ₹ 5,402.6 Cr |
Net Profit(TTM) | : | ₹ 117.1 Cr |
EPS (TTM) | : | ₹ 26.9 |
P/E (TTM) | : | 41.1 |
Industry Peers & Returns | 1W | 1M | 1Y |
ENTERO HEALTHCARE SOLUTIONS | -1.3% | -2.2% | -16.2% |
ADANI ENTERPRISES | 0.9% | 6.1% | -17.6% |
REDINGTON | -3.6% | -8% | 50.2% |
MMTC | -1.6% | 3% | -18.7% |
HONASA CONSUMER | -1.4% | -7.9% | -34.5% |
LLOYDS ENTERPRISES | 0.4% | -0.8% | 48.8% |
OPTIEMUS INFRACOM | -6.9% | -5.2% | -14.6% |
POLO QUEEN INDUSTRIAL & FINTECH | -0.9% | -20.1% | -5.6% |
MSTC | 1.2% | 0.3% | -23.2% |
ENTERO HEALTHCARE SOLUTIONS Revenues
[BOM: 544122|NSE : ENTERO]
Y-o-Y | 18.85 % |
5 Yr CAGR | 21.84 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2025 | ₹3,922 Cr | 18.85 | |
Mar2024 | ₹3,300 Cr | 30.85 | |
Mar2023 | ₹2,522 Cr | 41.71 | |
Mar2022 | ₹1,780 Cr | 0.00 | |
Mar2021 | ₹1,780 Cr | - |
ENTERO HEALTHCARE SOLUTIONS Operating Profit
[BOM: 544122|NSE : ENTERO]
Y-o-Y | 74.74 % |
5 Yr CAGR | 50.94 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹112 Cr | 74.74 | |
Mar2024 | ₹64 Cr | 161.92 | |
Mar2023 | ₹24 Cr | 13.43 | |
Mar2022 | ₹22 Cr | 0.00 | |
Mar2021 | ₹22 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | 46.91 % |
5 Yr CAGR | 23.88 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2025 | 2.85% | 46.91 | |
Mar2024 | 1.94% | 100.00 | |
Mar2023 | 0.97% | -19.83 | |
Mar2022 | 1.21% | 0.00 | |
Mar2021 | 1.21% | - |
ENTERO HEALTHCARE SOLUTIONS Profit After Tax
[BOM: 544122|NSE : ENTERO]
Y-o-Y | Positive |
5 Yr CAGR | Positive |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹39 Cr | Positive | |
Mar2024 | ₹-12 Cr | Negative | |
Mar2023 | ₹-30 Cr | Negative | |
Mar2022 | ₹-16 Cr | Negative | |
Mar2021 | ₹-16 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | 108.91 % |
5 Yr CAGR | Positive |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2025 | 2.11 % | 108.91 | |
Mar2024 | 1.01 % | Positive | |
Mar2023 | -0.34 % | Negative | |
Mar2022 | -1.17 % | Negative | |
Mar2021 | -0.86 % | - |
ENTERO HEALTHCARE SOLUTIONS Earnings Per Share (EPS)
[BOM: 544122|NSE : ENTERO]
Y-o-Y | 142.38 % |
5 Yr CAGR | Positive |
Years | EPS | % Change | |
---|---|---|---|
Mar2025 | ₹22 | 142.38 | |
Mar2024 | ₹8.99 | Positive | |
Mar2023 | ₹-28 | Negative | |
Mar2022 | ₹-78 | Negative | |
Mar2021 | ₹-1,554 | - |
ENTERO HEALTHCARE SOLUTIONS Return on Capital Employed (ROCE)
[BOM: 544122|NSE : ENTERO]
Y-o-Y | 30.48 % |
5 Yr CAGR | 58.00 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2025 | 9.16% | 30.48 | |
Mar2024 | 7.02% | 40.68 | |
Mar2023 | 4.99% | 302.42 | |
Mar2022 | 1.24% | -15.65 | |
Mar2021 | 1.47% | - |
ENTERO HEALTHCARE SOLUTIONS Share Price vs Sensex
Current Share Price | : | ₹1,106.6 |
Current MarketCap | : | ₹ 4,813.5 Cr |
Updated EOD on | : | Oct 17,2025 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ENTERO HEALTHCARE SOLUTIONS | -1.3% |
-2.2% |
-16.2% |
SENSEX | 1.8% |
1.9% |
2.4% |
ENTERO HEALTHCARE SOLUTIONS related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
BSE ALLCAP | 6.4% | 8.9% | 7.5% |
BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
BSE CONSUMER DISCRETIONARY & SERVICES | 1.2% | -1% | -5.7% |
BSE SMALLCAP | -0.6% | -2.3% | -6.3% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY TOTAL MARKET | 1.1% | 0.8% | -0.9% |
NIFTY MICROCAP 250 | -0.7% | -2.9% | -8.5% |
You may also like the below Video Courses
FAQ about ENTERO HEALTHCARE SOLUTIONS Financials
How the annual revenues of ENTERO HEALTHCARE SOLUTIONS have changed ?
The Revenues of ENTERO HEALTHCARE SOLUTIONS have increased by 18.85% YoY .
How the Earnings per Share (EPS) of ENTERO HEALTHCARE SOLUTIONS have changed?
The Earnings Per Share (EPS) of ENTERO HEALTHCARE SOLUTIONS has increased by 142.38 % YoY .
Intrinsic Value of ADANI ENTERPRISES LTD Intrinsic Value of REDINGTON LTD Intrinsic Value of MMTC LTD Intrinsic Value of HONASA CONSUMER LTD Intrinsic Value of LLOYDS ENTERPRISES LTD |
ADANI ENTERPRISES LTD vs REDINGTON LTD vs MMTC LTD
HONASA CONSUMER LTD vs LLOYDS ENTERPRISES LTD vs